This virtual event will provide an update on a variety of chronic GVHD topics: diagnosis, treatment and patient pathways, nurses point of view, third line therapies and more.

TOPICS COVERED TO INCLUDE

• Diagnosis of cGVHD and definitions of steroid refractoriness
• Treatment of cGVHD and patient pathways
• Nurse point of view of cGVHD
• Which therapy should I select in third line?
• 30 years of ECP: from GVHD single agent to combination therapies

WHO SHOULD ATTEND?

• Consultants
• Registrars
• Scientists
• Nurses
• Quality Managers
• Data Managers

SPEAKERS

• Dr Daniele Avenoso
• Dr Sara Lozano Cerrada
• Michelle Kenyon
• Francesca Kinsella
• Maria Cuadrado

For more information, please contact: [email protected]k